Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
Study NCT ID:
NCT01551004
Status:
COMPLETED
Last Update Posted:
2017-09-25
First Post:
2012-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Single Dose of CRS3123
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2014-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-08
First Submit QC Date:
None
Study First Post Date:
2012-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-21
Last Update Post Date:
2017-09-25
Last Update Post Date Type:
ACTUAL